CEL-SCI (CVM +2.3%) gains after announcing that its longstanding collaboration with Northeast Ohio Medical University has produced a new investigational breast cancer vaccine which prevents and treats a HER-2/neu expressing breast cancer tumor in a mouse model of the disease. In addtion to finding an absence of tumors in lymph nodes or peritoneal membranes, the vaccine also demonstrated a reduction in the number of tumors and tumor mass.
CEL-SCI (CVM +2.3%) gains after announcing that its longstanding collaboration with Northeast...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs